STOCK TITAN

Genesco (GCO) activist group reports 8.7% stake and backs new board nominees

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Bradley Radoff, Jumana Capital and Christopher Martin amended their Schedule 13D on Genesco, disclosing beneficial ownership of 966,479 shares, or about 8.7% of the common stock outstanding. Radoff directly holds 460,000 shares, while Jumana Capital holds 506,479 shares, with Martin deemed a beneficial owner of Jumana’s stake.

The filing updates their intentions around the company’s board. On June 8, 2026, Radoff withdrew the nominations of Glen Herrick and Kashif Molwani for election at the annual meeting, while the group began soliciting proxies to elect Westervelt (Westy) Ballard Jr. and Paula Poskon instead. The group also amended its internal agreement to remove Herrick and Molwani as parties.

Positive

  • None.

Negative

  • None.

Insights

Activist group holding 8.7% of Genesco shifts board slate.

The reporting group of Bradley Radoff, Jumana Capital and Christopher Martin now reports beneficial ownership of 966,479 Genesco shares, or 8.7% of shares outstanding as of May 18, 2026. This positions them as a sizable shareholder bloc.

The amendment describes a change in their board strategy: withdrawal of two prior nominees and proxy solicitation for Westervelt Ballard Jr. and Paula Poskon. An amendment to the group agreement removes the withdrawn nominees from the investor group, clarifying who is formally aligned in the campaign.

For investors, the key takeaway is that an organized shareholder group with a mid‑single‑digit stake is actively pursuing board representation through the upcoming annual meeting, which may influence Genesco’s governance direction depending on voting outcomes.

Radoff shares owned 460,000 shares Directly beneficially owned; approx. 4.1% of shares outstanding
Radoff aggregate purchase price $13,096,050 Aggregate purchase price for 460,000 shares, including commissions
Jumana Capital shares owned 506,479 shares Directly beneficially owned; approx. 4.6% of shares outstanding
Jumana Capital purchase price $15,475,590 Aggregate purchase price for 506,479 shares, including commissions
Group total ownership 966,479 shares Approx. 8.7% of Genesco shares outstanding as of May 18, 2026
Shares outstanding 11,103,175 shares Genesco shares outstanding as of May 18, 2026, per Schedule 14A
Schedule 13D regulatory
"Item 5(c) is hereby amended and restated to read as follows: The transactions in securities of the Issuer by the Reporting Persons since the filing of Amendment No. 1 to the"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
preliminary proxy statement regulatory
"the Reporting Persons filed a preliminary proxy statement with the Securities and Exchange Commission in connection with their solicitation of proxies"
A preliminary proxy statement is an advance draft of the information a company will send shareholders before a vote, outlining items like board elections, mergers, executive pay, and shareholder proposals. It matters to investors because it lays out what will be decided, management’s recommendations, and key facts that can affect a company’s direction and stock value — like receiving the agenda and background packet before a town-hall vote.
Schedule 14A regulatory
"Shares outstanding as disclosed in the Issuer's preliminary proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June 3, 2026"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
beneficial owner financial
"Mr. Martin, as the Manager of Jumana Capital, may be deemed the beneficial owner of the 506,479 Shares owned by Jumana Capital"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
margin loans financial
"personal funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business)"
Margin loans are loans from a brokerage that let an investor borrow money using their existing stocks, bonds or cash as collateral to buy more securities. They matter because borrowing magnifies both gains and losses—like using a lever to move a heavier load—so small market moves can have outsized effects on your returns; investors also pay interest and risk a margin call, where the broker may force sales if collateral falls below required levels.
group regulatory
"may be deemed to be a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





371532102

(CUSIP Number)
BRADLEY L. RADOFF
2727 Kirby Drive, Unit 29L,
Houston, TX, 77098
713-482-2196


CHRISTOPHER MARTIN
JUMANA CAPITAL INVESTMENTS LLC, 1717 St. James Place, Suite 335
Houston, TX, 77056
281-915-2704


RYAN NEBEL
OLSHAN FROME WOLOSKY LLP, 1325 Avenue of the Americas
New York, NY, 10019
212-451-2300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
06/08/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Radoff Bradley Louis
Signature:/s/ Bradley L. Radoff
Name/Title:Bradley L. Radoff
Date:06/10/2026
Jumana Capital Investments LLC
Signature:/s/ Christopher R. Martin
Name/Title:Christopher R. Martin, Manager
Date:06/10/2026
Martin Christopher Ross
Signature:/s/ Christopher R. Martin
Name/Title:Christopher R. Martin
Date:06/10/2026

FAQ

What stake in Genesco (GCO) do Bradley Radoff and Jumana Capital report?

The reporting group discloses beneficial ownership of 966,479 Genesco shares, representing about 8.7% of shares outstanding as of May 18, 2026, according to the issuer’s preliminary proxy statement.

How many Genesco (GCO) shares does Bradley Radoff personally own?

Bradley Radoff directly beneficially owns 460,000 Genesco shares, equal to approximately 4.1% of shares outstanding. The aggregate purchase price for these shares is about $13,096,050, including brokerage commissions.

What is Jumana Capital’s ownership in Genesco (GCO)?

Jumana Capital directly beneficially owns 506,479 Genesco shares, or roughly 4.6% of the company’s outstanding shares. The aggregate purchase price for this position is approximately $15,475,590, including brokerage commissions.

Which Genesco (GCO) board nominees are being supported by the reporting group?

The group is soliciting proxies to elect Westervelt (Westy) T. Ballard Jr. and Paula J. Poskon to Genesco’s board at the annual meeting, replacing earlier nominations that have now been withdrawn.

Which Genesco (GCO) board nominations were withdrawn by Bradley Radoff?

On June 8, 2026, Bradley Radoff withdrew the nominations of Glen W. Herrick and Kashif (Kash) Molwani for election to Genesco’s board at the annual meeting, and they were also removed as parties to the investor group agreement.

What share count underlies the reported 8.7% Genesco (GCO) ownership?

The reported ownership percentages are based on 11,103,175 Genesco shares outstanding as of May 18, 2026, as disclosed in the company’s preliminary proxy statement on Schedule 14A filed June 3, 2026.